Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. [electronic resource]
Producer: 20100729Description: 907-10 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Combined Modality Therapy
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Leukemia, Prolymphocytic, T-Cell -- therapy
- Male
- Middle Aged
- Retrospective Studies
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Letter; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.